Morgan Stanley Alector, Inc. Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALEC
# of Institutions
165Shares Held
57.8MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$47.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$27.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$24.3 Million0.69% of portfolio
-
State Street Corp Boston, MA2.79MShares$14.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT2.38MShares$12.5 Million0.34% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $433M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...